| PDF - Published Version (389kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-314977
- DOI to cite this document:
- 10.5283/epub.31497
Abstract
Background Chloroquine (CQ) and hydroxychloroquine (HCQ) are used to treat auto-immune related diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus. Both drugs however can cause retinal toxicity eventually leading to irreversible maculopathy and retinopathy. Established risk factors are duration and dosage of treatment while the involvement of genetic factors contributing to ...
Owner only: item control page